Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626989 · ClinicalTrials.gov registry record · NA
Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01626989: Completed NA study, sponsored by Philips Respironics.
NCT01626989 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01626989, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.
Primary Outcome
Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep.
Interventions
- DEVICE BiPAP auto Advanced
- DEVICE BiPAP auto SV4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT01626989 record still lists
NCT01626989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which BiPAP auto Advanced is the first listed.
NCT01626989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01626989 about?
NCT01626989 is a clinical study titled "Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders". Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.
What is the current status of trial NCT01626989?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2010-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01626989?
The interventions under investigation include: BiPAP auto Advanced (DEVICE), BiPAP auto SV4 (DEVICE).
Who is sponsoring clinical trial NCT01626989?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01626989's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia